About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Axatilimab + CAR-T for High-Risk Lymphoma

Axatilimab + CAR-T for High-Risk Lymphoma

NCT07638982·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Joseph Maakaron, MD
CONTACT
404-255-1930 jmaakaron@bmtga.com
Caitlin Guzowski, MBA, MHA, CCRC
CONTACT
404-851-8523 caitlin.guzowski@northside.com

Lead

Northside Hospital, Inc.

Age

8–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Age ≥ 18 years
Histologically confirmed large B-cell lymphoma
Presence of one or more high-risk features
Eligible to receive CAR-T according to the FDA label
Measurable disease by CT or PET
Adequate organ function unless related to lymphoma involvement:
Pulse oximetry ≥ 92% on room air
Ejection Fraction ≥ 40%
ALT/AST \< 5x ULN
Bilirubin \< 3 x ULN
Calculated or measured creatinine Clearance ≥ 30 mL/min

You may not be if

KPS \<60
Second malignancy with a high metastatic potential within 3 years
Active CNS involvement. Treated CNS disease is allowed
Active HBV or HCV infection.
Active uncontrolled infections
Known HIV positive status
Allogeneic transplant within 100 days of enrollment
Active acute or chronic graft versus host disease
History of acute or chronic pancreatitis
History of myositis

The record

StatusNot yet recruiting

PhasePhase 1

Taking part29

StartedOct 2026

UpdatedJun 10, 2026

Conditions

Diffuse Large B Cell Lymphoma (DLBCL)High-grade B-cell Lymphoma (HGBCL)High-Grade B-Cell Lymphoma, Nos PMBCL Follicular Grade 3 Lymphoma

Where1

Northside Hospital
Atlanta, Georgia, United States